Kinetic, Thermodynamic, and Crystallographic Studies of 2-Triazolylthioacetamides as Verona Integron-Encoded Metallo-β-Lactamase 2 (VIM-2) Inhibitor

被引:7
|
作者
Xiang, Yang [1 ,2 ]
Zhang, Yue-Juan [1 ]
Ge, Ying [1 ]
Zhou, Yajun [3 ,4 ]
Chen, Cheng [1 ]
Wahlgren, Weixiao Yuan [5 ]
Tan, Xiangshi [3 ,4 ]
Chen, Xi [1 ]
Yang, Ke-Wu [1 ]
机构
[1] Northwest Univ, Key Lab Synthet & Nat Funct Mol Chem, Chem Biol Innovat Lab, Minist Educ,Coll Chem & Mat Sci, Xian 710127, Shaanxi, Peoples R China
[2] Yanan Univ, Sch Phys Educ, Yanan 716000, Peoples R China
[3] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China
[4] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China
[5] Univ Gothenburg, Dept Chem & Mol Biol, Box 462, S-40530 Gothenburg, Sweden
基金
中国国家自然科学基金;
关键词
antibiotic resistance; metallo-beta-lactamase VIM-2 inhibitor; 2-triazolylthioacetamides; thermodynamics; crystallographic study; PSEUDOMONAS-AERUGINOSA; SCAFFOLD; TRIAZOLYLTHIOACETAMIDE; AZOLYLTHIOACETAMIDES; RESISTANCE; DISCOVERY; LEADS;
D O I
10.3390/biom10010072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of beta-lactamases presents a promising strategy to restore the beta-lactams antibacterial activity to resistant bacteria. In this work, we found that aromatic carboxyl substituted 2-triazolylthioacetamides 1a-j inhibited VIM-2, exhibiting an IC50 value in the range of 20.6-58.6 mu M. The structure-activity relationship study revealed that replacing the aliphatic carboxylic acid with aromatic carboxyl improved the inhibitory activity of 2-triazolylthioacetamides against VIM-2. 1a-j (16 mg/mL) restored the antibacterial activity of cefazolin against E. coli cell expressing VIM-2, resulting in a 4-8-fold reduction in MICs. The isothermal titration calorimetry (ITC) characterization suggested that the primary binding 2-triazolylthioacetamide (1b, 1c, or 1h) to VIM-2 was a combination of entropy and enthalpy contributions. Further, the crystal structure of VIM-2 in complex with 1b was obtained by co-crystallization with a hanging-drop vapour-diffusion method. The crystal structure analysis revealed that 1b bound to two Zn(II) ions of the enzyme active sites, formed H-bound with Asn233 and structure water molecule, and interacted with the hydrophobic pocket of enzyme activity center utilizing hydrophobic moieties; especially for the phenyl of aromatic carboxyl which formed pi-pi stacking with active residue His263. These studies confirmed that aromatic carboxyl substituted 2-triazolylthioacetamides are the potent VIM-2 inhibitors scaffold and provided help to further optimize 2-triazolylthioacetamides as VIM-2 even or broad-spectrum M beta Ls inhibitors.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Mutational Analysis of VIM-2 Reveals an Essential Determinant for Metallo-β-Lactamase Stability and Folding
    Borgianni, Luisa
    Vandenameele, Julie
    Matagne, Andre
    Bini, Luca
    Bonomo, Robert A.
    Frere, Jean-Marie
    Rossolini, Gian Maria
    Docquier, Jean-Denis
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) : 3197 - 3204
  • [32] Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece
    Mavroidi, A
    Tsakris, A
    Tzelepi, E
    Pournaras, S
    Loukova, V
    Tzouvelekis, LS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 1041 - 1043
  • [33] Multispecies Outbreak of Verona Integron-Encoded Metallo-β-Lactamase-Producing Multidrug-Resistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2 Plasmid
    de Man, Tom J. B.
    Yaffee, Anna Q.
    Zhu, Wenming
    Batra, Dhwani
    Alyanak, Efe
    Rowe, Lori A.
    McAllister, Gillian
    Moulton-Meissner, Heather
    Boyd, Sandra
    Flinchum, Andrea
    Slayton, Rachel B.
    Hancock, Steven
    Walters, Maroya Spalding
    Halpin, Alison Laufer
    Rasheed, James Kamile
    Noble-Wang, Judith
    Kallen, Alexander J.
    Limbago, Brandi M.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (03) : 414 - 420
  • [34] Efficacy of Humanized High-Dose Meropenem, Cefepime, and Levofloxacin against Enterobacteriaceae Isolates Producing Verona Integron-Encoded Metallo-β-Lactamase (VIM) in a Murine Thigh Infection Model
    Ghazi, Islam M.
    Crandon, Jared L.
    Lesho, Emil P.
    McGann, Patrick
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (11) : 7145 - 7147
  • [35] Successful treatment of Verona integron-encoded metallo-β-lactamase-producing Klebsiella pneumoniae infection using the combination of ceftazidime/avibactam and aztreonam
    Pelaez Bejarano, Ana
    Sanchez-del Moral, Raquel
    Montero-Perez, Olalla
    Javier Martinez-Marcos, Francisco
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (02) : 113 - 115
  • [36] Detection of Pseudomonas aeruginosa producing metallo-β-lactamase VIM-2 in a central hospital from Portugal
    A. Pena
    A. M. Donato
    A. F. Alves
    R. Leitão
    O. M. Cardoso
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 1269 - 1271
  • [37] Detection of Pseudomonas aeruginosa producing metallo-β-lactamase VIM-2 in a central hospital from Portugal
    Pena, A.
    Donato, A. M.
    Alves, A. F.
    Leitao, R.
    Cardoso, O. M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (12) : 1269 - 1271
  • [38] Synthesis of Metallo-β-Lactamase VIM-2 Is Associated with a Fitness Reduction in Salmonella enterica Serovar Typhimurium
    Cordeiro, Nicolas F.
    Chabalgoity, Jose A.
    Yim, Lucia
    Vignoli, Rafael
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 6528 - 6535
  • [39] VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa
    Jacobson, Rachael Kiera
    Minenza, Nadia
    Nicol, Mark
    Bamford, Colleen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (07) : 1797 - 1798
  • [40] Molecular characterization of Pseudomonas aeruginosa isolates in Cantabria, Spain, producing VIM-2 metallo-β-lactamase
    Rodriguez, Maria-Cruz
    Ruiz del Castillo, Belen
    Rodriguez-Mirones, Cristina
    Romo, Maria
    Monteagudo, Idoia
    Martinez-Martinez, Luis
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (02): : 99 - 103